G. Cincilla

2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease

J. Ballesteros, M. Loza, J. Brea, 2022, Journal of medicinal chemistry.

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

Manisha Ray, M. López-Rodríguez, S. Ortega‐Gutiérrez, 2022, Journal of medicinal chemistry.

An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel Antimalarials.

Benedict Irwin, Benedict W J Irwin, Gareth Conduit, 2020, Journal of medicinal chemistry.

A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration.

J. Chun, A. Ferrer-Montiel, R. Rivera, 2019, Journal of medicinal chemistry.

Individual and collective human intelligence in drug design: evaluating the search strategy

Jascha Blobel, G. Cincilla, Simone Masoni, 2020, Journal of Cheminformatics.

Structuring Chemical Space: Similarity‐Based Characterization of the PubChem Database

Michael Thormann, Miquel Pons, Giovanni Cincilla, 2010, Molecular informatics.

Individual and collective human intelligence in drug design: evaluating the search strategy

Giovanni Cincilla, Simone Masoni, Jascha Blobel, 2021, Journal of Cheminformatics.